Niels Brock Copenhagen Business College

Tetra Pharm Technologies strengthens management board

Retrieved on: 
Tuesday, May 16, 2023
Tetra, Sclerosis, Communication, Marketing, Head, Overalls, Copenhagen Business School, CMO, Strategic planning, Business administration, Patient, Master of Science, Neuropathic pain, Trade, Niels Brock Copenhagen Business College, CFO, Knowledge, Growth, Tourism, Management, Renewable energy

COPENHAGEN, Denmark, May 16, 2023 /PRNewswire/ -- Tetra Pharm Technologies develops and manufactures pharmaceutical drugs targeting the endocannabinoid system for the treatment of neuropathic pain, sclerosis, and mental health disorders. The expansion of the management board is due to the company's increasing level of activity and ambition.

Key Points: 
  • The Danish biotech company, Tetra Pharm Technologies, is expanding its management board with Mr. Steen Jakobsen as Chief Financial Officer (CFO) and Mr. Jacob Schlundt as Chief Marketing Officer (CMO).
  • "Tetra Pharm Technologies has reached a size that makes it necessary to expand the management board.
  • Steen Jakobsen brings solid experience in strategic planning, finance, and management, and he will take responsibility of the overall finance function at Tetra Pharm Technologies.
  • Tetra Pharm Technologies has recruited Jacob Schlundt from a role as Head of Marketing & Communications at Aon Denmark, and he brings extensive knowledge within marketing, communication, and event planning to strengthen Tetra Pharm Technologies' global position and profile.

Tetra Pharm Technologies strengthens management board

Retrieved on: 
Tuesday, May 16, 2023
Tetra, Sclerosis, Communication, Marketing, Head, Overalls, Copenhagen Business School, CMO, Strategic planning, Business administration, Patient, Master of Science, Neuropathic pain, Trade, Niels Brock Copenhagen Business College, CFO, Knowledge, Growth, Tourism, Management, Renewable energy

COPENHAGEN, Denmark, May 16, 2023 /PRNewswire/ -- Tetra Pharm Technologies develops and manufactures pharmaceutical drugs targeting the endocannabinoid system for the treatment of neuropathic pain, sclerosis, and mental health disorders. The expansion of the management board is due to the company's increasing level of activity and ambition.

Key Points: 
  • The Danish biotech company, Tetra Pharm Technologies, is expanding its management board with Mr. Steen Jakobsen as Chief Financial Officer (CFO) and Mr. Jacob Schlundt as Chief Marketing Officer (CMO).
  • "Tetra Pharm Technologies has reached a size that makes it necessary to expand the management board.
  • Steen Jakobsen brings solid experience in strategic planning, finance, and management, and he will take responsibility of the overall finance function at Tetra Pharm Technologies.
  • Tetra Pharm Technologies has recruited Jacob Schlundt from a role as Head of Marketing & Communications at Aon Denmark, and he brings extensive knowledge within marketing, communication, and event planning to strengthen Tetra Pharm Technologies' global position and profile.